vimarsana.com

Page 16 - மருந்து நிறுவனம் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index

Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index Wednesday, January 27, 2021 11:40AM IST (6:10AM GMT)   Company Ranked Sixth Overall and Leads the Pharmaceutical Industry in Governance of Access Secured Industry-Leading Positions in All Three Technical Areas Evaluated Shows Strong Performance in Health System Strengthening and Compliance   (TSE:4502/NYSE:TAK) (“Takeda”) has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company achieved notable, high scores in all three technical areas evaluated by the Index, including being ranked first in Governance of Access. Takeda also demonstrated strong performance in the areas of health system strengthening, compliance and R&D capacity building, according to the Index.

Takeda Achieved Carbon Neutrality in 2020

Share: Focus on Energy Conservation, Renewable Energy and Carbon Offsets Achievement Represents a Significant Milestone in the Company s Commitment to Become Carbon Zero in its Operations by 2040 Takeda Pharmaceutical Company Limited ((TAK) ( Takeda ) today announced that it achieved carbon neutrality in its value chain for its fiscal year 2019. This achievement was delivered by a continued focus on internal energy conservation measures, procurement of green energy, and investment in renewable energy certificates and high-quality, verified carbon offsets. These actions collectively address 100 percent of Takeda s fiscal year 2019 scope 1, 2, and 3 emissions 1 and represent a significant milestone in Takeda s sustainability journey. This important milestone underscores our commitment to environmental sustainability as we recognize that climate change poses a risk to human health, including the spread of some of the same infectious diseases we re working to eradicate, said Chris

PatientsLikeMe LLC: PatientsLikeMe Partners With Takeda to Empower Patients and Elevate Patient Voice to the Level of Evidence

(2) CAMBRIDGE, MA / ACCESSWIRE / January 26, 2021 / The world s largest integrated community, health management, and real-world data platform PatientsLikeMe announced today it is partnering with Takeda Pharmaceutical Company Limited ( Takeda ). PatientsLikeMe announces a strategic partnership to optimize technology to enhance understanding of the patient experience and improve patients ability to partner effectively with their healthcare teams. PatientsLikeMe and Takeda will enhance the digital platform and gather insights on the patient experience and unmet needs, with an initial focus on Rare Diseases, Immunology, Neuroscience/Mental Health and Gastroenterology. The partnership seeks to enhance understanding of patients treatment goals and optimize patient engagement. The information obtained through the partnership will inform the development of digital shared decision making and educational tools that will enhance patient engagement in treatment decisions and disease managem

Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index

Press release content from Business Wire. The AP news staff was not involved in its creation. Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index January 26, 2021 GMT ( TSE:4502/NYSE:TAK ) (“Takeda”) has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company achieved notable, high scores in all three technical areas evaluated by the Index, including being ranked first in Governance of Access. Takeda also demonstrated strong performance in the areas of health system strengthening, compliance and R&D capacity building, according to the Index. ADVERTISEMENT “This honor underscores Takeda’s commitment to prioritizing patient needs by ensuring access to our life-transforming treatments,” said Christophe Weber, Takeda president and chief executive officer. “As a purpose-driven company that puts the patient at the center of everything we do, we are committed to not just inventing

Redirecting to Takeda Named Global Top Employer for Fourth Consecutive Year

Takeda Named Global Top Employer for Fourth Consecutive Year Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receiving the global certification for the fourth consecutive year, Takeda was also certified as a Top Employer in four regions and 38 countries. This underscores the company’s commitment to creating an exceptional people experience for its global workforce. For more than 30 years, Top Employers Institute has given annual award certification to companies with outstanding culture, work environments, benefits and opportunities for their people. The Institute certifies organizations based on the results of its HR Best Practices Survey. The survey covers 20 people-centric topic areas, including Career Development, Culture, Diversity & Inclusion, Learning, Sustainability, Values, Well-being and Work Environment.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.